LSDIF

0.00010.00%
CB

Charles B. Nemeroff

Member of Scientific Advisory Board

Dr. Charles B. Nemeroff, M.D. Ph.D. is Member of Clinical Advisory Board at Sensorium Therapeutics, Inc. from May 2026. He is Advisor of Headlamp Health, Inc. Prof. Dr. Nemeroff serves as Member of Clinical Advisory Board at Incannex Healthcare Inc. since January 2026. He serves as Member of Scientific Advisory Board at Silo Pharma Inc. since December 2020. He served as Member of Scientific Advisory Board at Pasithea Therapeutics Corp. Prof. Nemeroff was Member of Advisory Board of Reunion Neuroscience Inc. from 2025 until 2025 and serves as its Member of Science Advisory Board since 2025. Prof. Nemeroff is a Consultant to various pharmaceutical companies including Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Merck, Inc. Otsuka Pharmacia/Upjohn, Somerset Pharmaceuticals and Wyeth-Ayerst Laboratories. He serves as Chairman of the Medical Advisory Board of Senseye, Inc. He has served as Director of Lucy Scientific Discovery Inc. since November 2021 and serves as its Independent Director. He is Professor and Chair of the Department of Psychiatry and Behavioral Sciences at the University of Texas Dell Medical School since October 2018 and May 2019 respectively. Since 2018, Prof. Nemeroff founded and served as the Chief Scientific Officer of EMA Wellness, a company focused on collection and analysis of Ecological Momentary Assessments and digital biomarkers in clinical trials. He is a Matthew P. Nemeroff Endowed Chair. He is co-editor in chief (with Alan F. Schatzberg, M.D.) of the Textbook of Psychopharmacology, published by the APA Press and now in its Fifth Edition. Prof. Nemeroff serves as Editor-in-Chief of Neuropsychopharmacology. He served as the Editor-in-Chief of the Psychopharmacology Bulletin, Associate Editor of Biological Psychiatry and both Critical Reviews in Neurobiology and Depression and Anxiety. Prof. Nemeroff served as Consultant at Cypress Bioscience, Inc. He has extensive drug development experience consulting with a number small and large pharmaceutical R&D companies. Prof. Nemeroff serves as Professor at Reunette W. Harris. Dr. Nemeroff serves as Chairman of Scientific Advisory Board at Novadel Pharma Inc. He is the co-editor in chief of a new journal published by Elsevier, Personalized Medicine in Psychiatry. He serves as Co-Chairman of Scientific Advisory Board of CeNeRx BioPharma, Inc. In 2005, he also founded CeNeRx BioPharma, a drug development company that engages in developing therapeutics to treat diseases related to the nervous system. Prof. Nemeroff serves on the scientific advisory boards of numerous pharmaceutical companies including, Astra Pharmaceuticals, Forest Laboratories, Janssen, Organon, GlaxoSmithKline and Wyeth-Ayerst. He serves as Member of Scientific Advisory Board at Corcept Therapeutics Inc. and PharmaNeuroBoost NV. Prof. Nemeroff serves as a Member of Advisory Board at The Chatham Institute. Dr. Nemeroff serves as Member of Scientific Advisory Board at TPD LLC, PharmaNeuroBoost NV. Corcept Therapeutics Incorporated. He serves as Director at Mt. Cook Pharma, Inc. since June 2007. Prof. Nemeroff served as Director at Novadel Pharma Inc. since September 15, 2003 until January 2012. He served as Member of the Clinical Advisory Board at ACADIA Pharmaceuticals, Inc. Prof. Nemeroff served as a Member of Scientific Advisory Board of Cypress Bioscience Inc. He served as Director of Cypress Bioscience Inc. from March 2001 to March 25, 2004. Prof. Nemeroff served on the Mental Health Advisory Council of the National Institute of Mental Health and the biomedical Research Council for NASA. He is recognized internationally for his many scientific contributions and author of more than 500 publications. Prof. Nemeroff has served as the President of the American College of Psychiatrists and the American College of Neuropsychopharmacology and sits on the Scientific Advisory Board of the Brain and Behavior Research Foundation. He has received numerous awards for his research including the Society of Biological Psychiatry, Bowis Award from the American College of Psychiatrists and the Menninger Prize from the American College of Physicians and the Selo Prize from the National Alliance for Research in Schizophrenia and Depression and the Research Award in Mood Disorders from the American College of Psychiatrists. Prof. Nemeroff holds University Affiliation of Emory University, Psychiatry. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences. He also directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. From December 2009 to October 2018, he was a professor and served as the Chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami, Miller School of Medicine, in Miami, Florida. He held faculty positions at Duke University Medical Center and at Emory University School of Medicine before relocating to the University of Miami in 2009. Since January 2020, Prof. Nemeroff has served as the elected president of Anxiety and Depression Association of America (ADAA). Prof. Nemeroff serves as Member of Clinical Advisory Board at Navitor Pharmaceuticals, Inc. His research is focused on the pathophysiology of mood and anxiety disorders and he has published more than 1,100 research reports and reviews. Prof. Nemroff has received numerous research and education awards, including the Kempf Award in Psychobiology, the Samuel Hibbs Award, Research Mentoring Award, Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA), the Mood Disorders Award, Bowis Award and Dean Award from the American College of Psychiatrists (ACP) and the Julius Axelrod Award for mentoring from the ACNP. He sits on the Scientific Advisory Board of the Brain and Behavioral Research Foundation. He completed psychiatry residency training at UNC and Duke University. Prof. Nemeroff received his B.S. from the City College of New York, his Master of Science degree (M.S.) in Biology from Northeastern University. He received Ph.D. Post doctorate and M.D. in neurobiology from the University of North Carolina School of Medicine, Chapel Hill.

公司職務